Technological changes continue to alter consumer behaviour, as well as the insurance landscape.

Aon identifies high-cost claimants and inflation as causes of the increase.

Suggests know-your-patient requirement be added to standards for virtual care.

Considered aesthetic medications, drugs for treating obesity are not covered by public healthcare systems.

Statistics Canada report examines medication use, out of pocket spending and non-adherence.

The Snowbird travel insurance business is back in full force as the pandemic subsides, but inflation could be a spoiler.

Biologic drugs, mental health and diabetes, all significant cost drivers, were each examined at a recent webinar.